Correlation Between Inhibrx and POINT Biopharma
Can any of the company-specific risk be diversified away by investing in both Inhibrx and POINT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and POINT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and POINT Biopharma Global, you can compare the effects of market volatilities on Inhibrx and POINT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of POINT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and POINT Biopharma.
Diversification Opportunities for Inhibrx and POINT Biopharma
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inhibrx and POINT is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and POINT Biopharma Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on POINT Biopharma Global and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with POINT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of POINT Biopharma Global has no effect on the direction of Inhibrx i.e., Inhibrx and POINT Biopharma go up and down completely randomly.
Pair Corralation between Inhibrx and POINT Biopharma
If you would invest 906.00 in POINT Biopharma Global on September 3, 2024 and sell it today you would earn a total of 0.00 from holding POINT Biopharma Global or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Inhibrx vs. POINT Biopharma Global
Performance |
| Timeline |
| Inhibrx |
| POINT Biopharma Global |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inhibrx and POINT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and POINT Biopharma
The main advantage of trading using opposite Inhibrx and POINT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, POINT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in POINT Biopharma will offset losses from the drop in POINT Biopharma's long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| POINT Biopharma vs. Oric Pharmaceuticals | POINT Biopharma vs. Lyra Therapeutics | POINT Biopharma vs. Inhibrx | POINT Biopharma vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |